Quick Answer
Pharmagreen Biotech Inc. reported Stockholders Equity of -$1.82 million for fiscal year 2022.
Pharmagreen Biotech Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2022 | -$1.82M | -7.7% |
| 2021 | -$1.69M | +42.3% |
| 2020 | -$2.93M | -251.6% |
| 2019 | -$834.5K | +39.9% |
| 2018 | -$1.39M | +42.1% |
| 2017 | -$2.40M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| June 30, 2023 | -$2.10M | -11.3% | -8.4% |
| March 31, 2023 | -$1.94M | +19.2% | -10.9% |
| December 31, 2022 | -$1.75M | -10.5% | +1.4% |
| September 30, 2022 | -$1.78M | -7.9% | +6.1% |
| June 30, 2022 | -$1.89M | -2.7% | +21.3% |
| March 31, 2022 | -$2.40M | -28.4% | -51.6% |
| December 31, 2021 | -$1.58M | +9.6% | +3.7% |
| September 30, 2021 | -$1.65M | +43.9% | +10.6% |
- Pharmagreen Biotech Inc. showed a decrease of -7.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2017–2022 period, Pharmagreen Biotech Inc.’s stockholders equity has grown by 24.0% (from -$2.40 million to -$1.82 million).
- The most recent figure is from Pharmagreen Biotech Inc.’s fiscal year 2022 report (Form 10-K), filed with the SEC on January 17, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: